Cited by 3,104Cervical Cancer and HPV ResearchClinical practice guidelines implementationWomen's cancer prevention and management

The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Solomon, Diane·2002·JAMA

DOI 10.1001/jama.287.16.2114

Open this paper in CoChat — free account

Abstract

Objectives The Bethesda 2001 Workshop was convened to evaluate and update the 1991 Bethesda System terminology for reporting the results of cervical cytology. A primary objective was to develop a new approach to broaden participation in the consensus process. Participants Forum groups composed of 6 to 10 individuals were responsible for developing recommendations for discussion at the workshop. Each forum group included at least 1 cytopathologist, cytotechnologist, clinician, and international representative to ensure a broad range of views and interests. More than 400 cytopathologists, cytotechnologists, histopathologists, family practitioners, gynecologists, public health physicians, epidemiologists, patient advocates, and attorneys participated in the workshop, which was convened by the National Cancer Institute and cosponsored by 44 professional societies. More than 20 countries were represented. Evidence Literature review, expert opinion, and input from an Internet bulletin board were all considered in developing recommendations. The strength of evidence of the scientific data was considered of paramount importance. Consensus process Bethesda 2001 was a year-long iterative review process. An Internet bulletin board was used for discussion of issues and drafts of recommendations. More than 1000 comments were posted to the bulletin board over the course of 6 months. The Bethesda Workshop, held April 30-May 2, 2001, was open to the public. Postworkshop recommendations were…

Integrity signals

Registry

Crossref · 10.1001/jama.287.16.2114

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,297
2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
Wright, T. C. (2002) · JAMA · doi:10.1001/jama.287.16.2120 · Cited by 1,197
Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial
Solomon, D., SCHIFFMAN, M. H., & Tarone, R. E. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.293 · Cited by 958
Self-citation
The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses: Developed and approved at the national cancer institute workshop in Bethesda, MD, December 12–13, 1988
Soloman, D. (1989) · Diagnostic Cytopathology · doi:10.1002/dc.2840050318 · Cited by 290
Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories.
Jones, B. A., & Novis, D. A. (1996) · PubMed · Cited by 181
Qualification of ASCUS
Sherman, M. E., Solomon, D., SCHIFFMAN, M. H., & for the ALTS Group (2001) · American Journal of Clinical Pathology · doi:10.1309/jm3v-u4hp-w8hj-68xv · Cited by 171
Self-citation
Atypical Epithelial Cells and Specimen Adequacy
Davey, D. D., Woodhouse, S. L., Styer, P. E., Stastny, J. F., & Mody, D. R. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0203-aecasa · Cited by 134
The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses.
Hudson, E. A., Dv, C., & Brown, C. L. (1990) · PubMed · Cited by 130
Rapid Communication—The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses—Report of the 1991 Bethesda Workshop
Broder, S. E. (1992) · JAMA · doi:10.1001/jama.1992.03480140014005 · Cited by 127

Show all 29 references

Sorted by citations

Human papillomavirus and cervical cancer
SCHIFFMAN, M. H., Castle, P. E., Jerónimo, J., Rodríguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 3,135
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,077
Sexually Transmitted Diseases Treatment Guidelines, 2010
Workowski, K., & BOLAN, G. A. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,074
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Villa, L. L., Costa, R. L. R., Petta, C. A., de Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,593
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
Wright, T. C. (2002) · JAMA · doi:10.1001/jama.287.16.2120 · Cited by 1,197
The Pap Test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2015.03.003 · Cited by 1,149
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand, M., Duarte‐Franco, E., Rodrigues, I., Walter, S. D., Hanley, J. A., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,106
The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
Khan, M. J., Castle, P. E., Lorincz, A. T., Wacholder, S., Sherman, M. E., Scott, D. R., Rush, B. B., Glass, A. G., & SCHIFFMAN, M. H. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji187 · Cited by 1,073
ACOG PRACTICE BULLETIN
Gynecologists (2009) · Cited by 1,035
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T. H., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.lgt200570 · Cited by 1,014
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis
Machalek, D. A., Poynten, M., Jin, F., Fairley, C. K., Farnsworth, A., Garland, S. M., Hillman, R. J., Petoumenos, K., Roberts, J. M., Tabrizi, S. N., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70080-3 · Cited by 984
Human papillomavirus molecular biology and disease association
Doorbar, J., Egawa, N., Griffin, H. M., Kranjec, C., & Murakami, I. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1822 · Cited by 1,019
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Massad, L. S., Einstein, M. H., Huh, W. K., Katki, H. A., Kinney, W., Schiffman, M., Solomon, D., Wentzensen, N., & Lawson, H. W. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182883a34 · Cited by 927
Self-citation
American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
Saslow, D., Runowicz, C. D., Solomon, D., Moscicki, A.-B., Smith, R. A., Eyre, H. J., & Cohen, C. J. (2002) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.342 · Cited by 913
Self-citation
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Aberg, J. A., Kaplan, J. E., Libman, H., Emmanuel, P. J., Anderson, J., Stone, V. E., Oleske, J. M., Currier, J. S., & Gallant, J. E. (2009) · Clinical Infectious Diseases · doi:10.1086/605292 · Cited by 831
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.047 · Cited by 829
Self-citation
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
Villa, L. L., Costa, R. L. R., Petta, C. A., de Andrade, R. P., Paavonen, J. A., Iversen, O. L. E. E., Olsson, S., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603469 · Cited by 801
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Massad, L. S., Einstein, M. H., Huh, W. K., Katki, H. A., Kinney, W., Schiffman, M., Solomon, D., Wentzensen, N., & Lawson, H. W. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318287d329 · Cited by 740
Self-citation
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
Arbyn, M., Verdoodt, F., Snijders, P. J. F., Verhoef, V. M. J., Suonio, E., Dillner, L., Minozzi, S., Bellisario, C., Banzi, R., Zhao, F.-H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70570-9 · Cited by 674
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
Arbyn, M., Xu, L., Simoens, C., & Martin-Hirsch, P. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009069.pub3 · Cited by 621
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
Wright, T. C., Stoler, M. H., Behrens, C. M., Sharma, A., Zhang, G., & Wright, T. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.11.076 · Cited by 601
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Katki, H. A., Kinney, W., Fetterman, B. J., Lorey, T. S., Poitras, N. E., Cheung, L. C., Demuth, F., SCHIFFMAN, M. H., Wacholder, S., & Castle, P. E. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70145-0 · Cited by 581
The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated Lesions
Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T. H., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31826916c7 · Cited by 568
Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance
(2003) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00418-6 · Cited by 560
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Castle, P. E., Stoler, M. H., Wright, T. C., Sharma, A., Wright, T. L., & Behrens, C. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70188-7 · Cited by 537
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Rijkaart, D., Berkhof, J. H., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W. J., Heideman, D. A. M., Kenter, G. G., Cuzick, J. M., Snijders, P. J. F., & Meijer, C. J. L. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 530
Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P. J., Zingman, B. S., & Horberg, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit665 · Cited by 501
Cytology versus HPV testing for cervical cancer screening in the general population
Koliopoulos, G., Nyaga, V. N., Santesso, N., Bryant, A., Martin-Hirsch, P. P., Mustafa, R. A., Schünemann, H., Paraskevaidis, E., & Arbyn, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008587.pub2 · Cited by 494
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions
Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T. H., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31825c31dd · Cited by 493
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial
Muñóz, N., Manalastas, R., Pitisuttithum, P., Tresukosol, D., Monsonégo, J., Ault, K. A., Clavel, C., Luna, J., Myers, E. R., Hood, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60691-7 · Cited by 484
Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort Analysis
Sherman, M. E., Lorincz, A. T., Scott, D. R., Wacholder, S., Castle, P. E., Glass, A. G., Mielzynska, I., Rush, B. B., & SCHIFFMAN, M. H. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.46 · Cited by 429
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
The FUTURE I/II Study Group (2010) · BMJ · doi:10.1136/bmj.c3493 · Cited by 417
Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process
Leyden, W. A., Manos, M. M., Geiger, A. M., Weinmann, S. A., Mouchawar, J., Bischoff, K. J., Yood, M. U., Gilbert, J., & Taplin, S. H. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji115 · Cited by 390
Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia
Arbyn, M., Buntinx, F., Ranst, M. A. V., Paraskevaidis, E. A., Martin‐Hirsch, P. L., & Dillner, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh037 · Cited by 357
Diseases associated with human papillomavirus infection
Cubie, H. (2013) · Virology · doi:10.1016/j.virol.2013.06.007 · Cited by 354
2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests
Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3181585870 · Cited by 353
Self-citation
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
Castellsagué, X., Muñóz, N., Pitisuttithum, P., Ferris, D. G., Monsonégo, J., Ault, K. A., Luna, J., Myers, E. R., Mallary, S., Bautista, O. M., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.185 · Cited by 358
Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy
Cox, J. T., SCHIFFMAN, M. H., & Solomon, D. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.461 · Cited by 350
Self-citation
The Pap test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Cancer Cytopathology · doi:10.1002/cncy.21521 · Cited by 340
Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs
Kulasingam, S. (2003) · JAMA · doi:10.1001/jama.290.6.781 · Cited by 338
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
Kjær, S. K., Sigurðsson, K., Iversen, O., Hernández‐Ávila, M., Wheeler, C. M., Pérez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., Garcia, P. J., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0031 · Cited by 338
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
Stoler, M. H., Wright, T. C., Sharma, A., Apple, R. J., Gutekunst, K. A., & Wright, T. L. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpz5jy6fcvnmot · Cited by 333
Human Papillomavirus Infection and the Multistage Carcinogenesis of Cervical Cancer
Schiffman, M., & Wentzensen, N. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1406 · Cited by 344
Cervical Cancer: Prevention and Early Detection
Kessler, T. A. (2017) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2017.02.005 · Cited by 283
Cervical Cancer Prevention—Cervical Screening: Science in Evolution
Safaeian, M., Solomon, D., & Castle, P. E. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.09.004 · Cited by 267
Self-citation
Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science
Wentzensen, N., Sherman, M. E., SCHIFFMAN, M. H., & WANG, S. S. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.10.012 · Cited by 264
2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities
Wright, T. C., Cox, J. T., Massad, L. S., Twiggs, L. B., & Wilkinson, E. J. (2002) · Journal of Lower Genital Tract Disease · doi:10.1097/00128360-200204000-00012 · Cited by 256
Burden of cervical cancer and role of screening in India
Bobdey, S., Sathwara, J., Jain, A., & Balasubramaniam, G. (2016) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.195751 · Cited by 254
Findings to Date From the ASCUS-LSIL Triage Study (ALTS)
SCHIFFMAN, M. H., & Solomon, D. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-946-ftdfta · Cited by 249
Self-citation
Biomarkers in Cervical Cancer Screening
Wentzensen, N., & Doeberitz, M. V. K. (2007) · Disease Markers · doi:10.1155/2007/678793 · Cited by 242
Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease
Kane, S. V., Khatibi, B., & Reddy, D. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01582.x · Cited by 241
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort
Peto, J., Gilham, C., Deacon, J., Taylor, C., Evans, C., Wh, B., Haywood, M. E. K., Elanko, N., Coleman, D. V., Yule, R., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602049 · Cited by 238
The Pap Test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Acta Cytologica · doi:10.1159/000381842 · Cited by 236
CIN2 Is a Much Less Reproducible and Less Valid Diagnosis than CIN3
Carreon, J. D., Sherman, M. E., Guillén, D., Solomon, D., Herrero, R., Jerónimo, J., Wacholder, S., Rodríguez, A. C., Morales, J., Hutchinson, M. L., et al. (2007) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31805152ab · Cited by 234
Self-citation
p16/ki‐67 dual‐stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology
Schmidt, D., Bergeron, C., Denton, K. J., Ridder, R., & for the European CINtec Cytology Study Group (2011) · Cancer Cytopathology · doi:10.1002/cncy.20140 · Cited by 231
Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy
Wentzensen, N., Walker, J. L., Gold, M. A., Smith, K., Zuna, R. E., Mathews, C. A., Dunn, S. T., Zhang, R., Moxley, K. M., Bishop, E. A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9948 · Cited by 230
Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
Ikenberg, H., Bergeron, C., Schmidt, D., Griesser, H., Quitllet, F. A., Angeloni, C., Bogers, J., Dachez, R., Denton, K. J., Hariri, J., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt235 · Cited by 230
Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology
Petry, K. U., Schmidt, D., Scherbring, S., Luyten, A., Reinecke‐Lüthge, A., Bergeron, C., Kommoss, F., Löning, T., Ordï, J., Regauer, S., et al. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.02.033 · Cited by 228
Fourier transform infrared (FTIR) spectral mapping of the cervical transformation zone, and dysplastic squamous epithelium
Wood, B. R., Chiriboga, L. A., Yee, H. T., Quinn, M. A., McNaughton, D., & Diem, M. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.028 · Cited by 225
Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results
Wright, T. C., Stoler, M. H., Sharma, A., Zhang, G., Behrens, C. M., & Wright, T. L. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcptus5exas6dkz · Cited by 225
Impact of HPV infection in adolescent populations
Moscicki, A. (2005) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2005.09.011 · Cited by 227
Age-Related Prevalence of Anal Cancer Precursors in Homosexual Men: The EXPLORE Study
Chin-Hong, P. V., Vittinghoff, E., Cranston, R., Browne, L., Buchbinder, S., Colfax, G. N., Costa, M. D., Darragh, T. M., Benet, D. J., Judson, F. N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji163 · Cited by 222
Bethesda 2001 Implementation and Reporting Rates: 2003 Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
Davey, D. D., Neal, M. H., Wilbur, D. C., Colgan, T. J., Styer, P. E., & Mody, D. R. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-1224-biarrp · Cited by 222
Human papillomavirus vaccination and cervical cancer risk
Rahangdale, L., Mungo, C., O’Connor, S., Chibwesha, C. J., & Brewer, N. T. (2022) · BMJ · doi:10.1136/bmj-2022-070115 · Cited by 228
The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea
Oh, H. Y., Kim, B.-S., Seo, S., Kong, J.-S., Lee, J. K., Park, S.-Y., Hong, K., Kim, H. K., & Kim, M. K. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.02.026 · Cited by 216
Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines
Katki, H. A., SCHIFFMAN, M. H., Castle, P. E., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Cheung, L. C., Raine‐Bennett, T. R., Gage, J. C., & Kinney, W. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318285423c · Cited by 213
Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More
Goldie, S. J., Kim, J. J., & Wright, T. C. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000120143.50098.c7 · Cited by 208
TSLC1 Gene Silencing in Cervical Cancer Cell Lines and Cervical Neoplasia
Steenbergen, R. D. M., Kramer, D., Braakhuis, B. J. M., Stern, P. L., Verheijen, R. H. M., Meijer, C. J. L. M., & Snijders, P. J. F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh031 · Cited by 204
The 2001 Bethesda System terminology.
Apgar, B. S., Zoschnick, L., & Wright, T. C. (2003) · PubMed · Cited by 203
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
Joura, E. A., Kjær, S. K., Wheeler, C. M., Sigurðsson, K., Iversen, O., Hernández‐Ávila, M., Pérez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.073 · Cited by 201
Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia--Nationwide Follow-up of Young Danish Women
Baldur‐Felskov, B., Dehlendorff, C., Munk, C., & Kjær, S. K. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt460 · Cited by 191
Mortality trends for cervical squamous and adenocarcinoma in the United States
Sherman, M. E., WANG, S. S., Carreon, J. D., & Devesa, S. S. (2005) · Cancer · doi:10.1002/cncr.20877 · Cited by 185
Prophylactic Efficacy of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Women with Virological Evidence of HPV Infection
The FUTURE II Study Group (2007) · The Journal of Infectious Diseases · doi:10.1086/522864 · Cited by 187
Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening
Wentzensen, N., Lahrmann, B., Clarke, M. A., Kinney, W., Tokugawa, D., Poitras, N. E., Locke, A., Bartels, L., Krauthoff, A., Walker, J. L., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa066 · Cited by 180
Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort
Chen, Y., Qiu, X., Wang, W., Li, D., Wu, A., Hong, Z., Di, W. J., & Qiu, L. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05324-9 · Cited by 179
Detection of Hypermethylated Genes in Women with and Without Cervical Neoplasia
Feng, Q., Balasubramanian, A., Hawes, S. E., Touré, P. S., Sow, P. S., Dem, A., Dembélé, B., Critchlow, C. W., Xi, L., Lu, H., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji041 · Cited by 179
Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
Herrero, R., Wacholder, S., Rodríguez, A. C., Solomon, D., González, P., Kreimer, A. R., Porras, C., Schussler, J. E., Jiménez, S., Sherman, M. E., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0131 · Cited by 180
Self-citation
Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program
Wentzensen, N., Clarke, M. A., Bremer, R. C., Poitras, N. E., Tokugawa, D., Goldhoff, P., Castle, P. E., SCHIFFMAN, M. H., Kingery, J. D., Grewal, K. K., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0306 · Cited by 174
Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial
Monsonégo, J., Cox, J. T., Behrens, C. M., Sandri, M. T., Franco, E. L., Yap, P., & Huh, W. K. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.551 · Cited by 179
The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening
Salit, I. E., Lytwyn, A., Raboud, J., Sano, M., Chong, S., Diong, C. C., Chapman, W. B., Mahony, J. B., & Tinmouth, J. (2010) · AIDS · doi:10.1097/qad.0b013e328339e592 · Cited by 170
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial
Qiao, Y., Wu, T., Li, R., Hu, Y., Wei, L., Li, C., Chen, W., Huang, S., Zhao, F., Li, M., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz074 · Cited by 175
Genomic Amplification of the Human Telomerase Gene (TERC) in Pap Smears Predicts the Development of Cervical Cancer
Heselmeyer‐Haddad, K., Sommerfeld, K., White, N. M. A., Chaudhri, N., Morrison, L. E., Palanisamy, N., Wang, Z. Y., Auer, G., Steinberg, W., & Ried, T. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62341-3 · Cited by 169
Pooled Analysis of a Self-Sampling HPV DNA Test as a Cervical Cancer Primary Screening Method
Zhao, F., Lewkowitz, A. K., Chen, F., Lin, M., Hu, S., Zhang, X., Pan, Q., Ma, J.-F., Niyazi, M., Li, C.-Q., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr532 · Cited by 170
European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1
Jordan, J. A., Arbyn, M., Martin‐Hirsch, P. L., Schenck, U., Jj, B., Silva, D. D., Anttila, A., Nieminen, P., & Prendiville, W. J. (2008) · Cytopathology · doi:10.1111/j.1365-2303.2008.00623.x · Cited by 167
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
Bulk, S., Berkhof, J. H., Bulkmans, N. W. J., Zielinski, G. D., Rozendaal, L., van Kemenade, F. J., Snijders, P. J. F., & Meijer, C. J. L. M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602915 · Cited by 164
Revised Terminology for Cervical Histopathology and Its Implications for Management of High-Grade Squamous Intraepithelial Lesions of the Cervix
Waxman, A. G., Chelmow, D. P., Darragh, T. M., Lawson, H. W., & Moscicki, A. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31827001d5 · Cited by 168
Clinical Significance of Atypical Glandular Cells on Cervical Cytology
Schnatz, P. F., Guile, M. W., O’Sullivan, D. M., & Sorosky, J. I. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000202401.29145.68 · Cited by 162
Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China
Zhao, F.-H., Lin, M. J., Chen, F., Hu, S.-Y., Zhang, R., Belinson, J. L., Sellors, J. W., Franceschi, S., Qiao, Y.-L., & Castle, P. E. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70256-4 · Cited by 158
Adults' Knowledge and Behaviors Related to Human Papillomavirus Infection
Holcomb, B., Bailey, J. M., Crawford, K., & Ruffin, M. T. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.1.26 · Cited by 158
The Bethesda System for Reporting Cervical Cytology
Nayar, R., Wilbur, D. C., & Solomon, D. (2008) · Elsevier eBooks · doi:10.1016/b978-141604208-2.10006-5 · Cited by 155
Self-citation
A population‐based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination
Wheeler, C. M., Hunt, W. C., Cuzick, J. M., Langsfeld, E. S., Pearse, A., Montoya, G. D., Robertson, M., Shearman, C. A., & Castle, P. E. (2012) · International Journal of Cancer · doi:10.1002/ijc.27608 · Cited by 154
Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: Results from a large academic womens hospital laboratory employing sensitive screening methods
Zhao, C., Florea, A. V., Oniśko, A., & Austin, R. M. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.019 · Cited by 149
Evaluation and Management of Anal Intraepithelial Neoplasia in HIV-Negative and HIV-Positive Men Who Have Sex with Men
Park, I. U., & Palefsky, J. M. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0090-7 · Cited by 149
Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3
Alonso, I., Torné, A., Puig‐Tintoré, L. M., Esteve, R., Quintó, L., Campo, E., Pahisa, J., & Ordï, J. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.04.016 · Cited by 149
Multiple Human Papillomavirus Infections with High Viral Loads Are Associated with Cervical Lesions but Do Not Differentiate Grades of Cervical Abnormalities
Schmitt, M., Depuydt, C., Benoy, I. H., Bogers, J., Antoine, J., Arbyn, M., & Pawlita, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00087-13 · Cited by 148
Susceptibility to cervical cancer: An overview
de Freitas, A. C., Gurgel, A. P. A. D., Chagas, B. S., Coimbra, E. C., & do Amaral, C. M. M. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.03.047 · Cited by 153

Authors: Solomon, D.
Affiliations: National Institutes of Health (US)
Corresponding author: Solomon, Diane
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2002-04-24
Volume: 287
Issue: 16
Pages: 2114
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.287.16.2114
OpenAlex: W2133765716
Cited by: 3,104
References: 29
Citations by year: 2026: 45 · 2025: 57 · 2024: 65 · 2023: 71 · 2022: 92 · 2021: 95 · 2020: 109 · 2019: 121 · 2018: 139 · 2017: 137 · 2016: 161 · 2015: 189 · 2014: 177 · 2013: 217 · 2012: 203
FWCI: 92.24
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords: Bethesda system, cervical cytology, cervical cancer screening, cervical neoplasia, consensus development, international cooperation
MeSH terms: Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Female, Humans, Laboratories, Terminology as Topic, Quality Control, Vaginal Smears

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks